NCS Healthcare of Kentucky Inc recalls Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister car…
- Recall date
- October 27, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0113-2024
- FDA classification
- Class III
- Brand / firm
- NCS Healthcare of Kentucky Inc
- Sold / distributed
- Nationwide USA
Why it was recalled
Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.
Get recall alerts
Free email alert whenever NCS Healthcare of Kentucky Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: NCS Healthcare of Kentucky Inc